Julie Lemieux
机构: Centre de recherche du CHU de Québec-Université Laval
每年引用次数
引用次数
引用: 4,128
H-指数: 28
I10-指数 : 58
出版物: 149
A Randomized Double-Blind Placebo-Controlled Trial of the Effect of Vitamin D3 Supplementation on Breast Density in Premenopausal Women.
Jacques Brisson , Sylvie Bérubé , Caroline Diorio , Benoît Mâsse
Cancer Epidemiology, Biomarkers & Prevention 26 ( 8) 1233 -1241
6
2017
Effect of Experience and Training on the Concordance and Precision of Strain Measurements
Tomoko Negishi , Kazuaki Negishi , Paaladinesh Thavendiranathan , Goo-Yeong Cho
JACC: Cardiovascular Imaging 10 ( 5) 518 -522
54
2017
Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial
Tomoko Negishi , Paaladinesh Thavendiranathan , Kazuaki Negishi , Thomas H. Marwick
Jacc-cardiovascular Imaging 11 ( 8) 1098 -1105
78
2018
Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy.
Diana Mihalcea , Philip Mottram , Ryoko Morimoto Ichikawa , Mark Nolan
Jacc-cardiovascular Imaging 11 ( 8) 1109 -1118
19
2018
Evaluation of eligibility and recruitment in breast cancer clinical trials.
Julie Lemieux , Geneviève Forget , Olyvia Brochu , Louise Provencher
The Breast 23 ( 4) 385 -392
2
2014
Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.
Daniela Furrer , Julie Lemieux , Marc-André Côté , Louise Provencher
The Breast 30 191 -196
9
2016
Impact of physical activity in group versus individual physical activity on fatigue in patients with breast cancer: A pilot study
Christine Desbiens , Myriam Filion , Marie-Chantale Brien , Jean-Charles Hogue
The Breast 35 8 -13
8
2017
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Christine Simmons , Daniel Rayson , Anil Abraham Joy , Jan-Willem Henning
Therapeutic Advances in Medical Oncology 14 17588359211066677
11
2022
Effect of metformin vs placebo on invasive disease--free survival in patients with breast cancer: the MA. 32 randomized clinical trial
Pamela J Goodwin , Bingshu E Chen , Karen A Gelmon , Timothy J Whelan
Jama 327 ( 20) 1963 -1973
32
2022
Factors associated with chemotherapy-induced peripheral neuropathy-related reduced taxane dose or premature discontinuation in women with early-stage breast cancer
Lynn R Gauthier , Lye-Ann Robichaud , Maud Bouffard , Frédérique Therrien
medRxiv 2021.09. 13.21263539 -2021.09. 13.21263539
2021
Abstract P4-12-01: Adherence with adjuvant endocrine therapy with or without Palbociclib in the PALLAS trial
Eileen Shinn , David Zahrieh , Angela DeMichele , Nick Zdenkowski
Cancer Research 82 ( 4_Supplement) P4 -P4
2022
Immunology Inhibitors
Erica L Mayer , Amylou C Dueck , Miguel Martin , Gabor Rubovszky
XENERA-1: A randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease
Peter Schmid , Javier Cortes , Ana Joaquim , Noelia Martínez Jañez
Breast Cancer Research 25 ( 1) 67 -67
7
2023
Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.
Paaladinesh Thavendiranathan , Tomoko Negishi , Emily Somerset , Kazuaki Negishi
Journal of the American College of Cardiology 77 ( 22) 2869 -2870
184
2021
Cardioprotection using strain-guided management of potentially cardiotoxic cancer therapy: 3-year results of the SUCCOUR trial
Tomoko Negishi , Paaladinesh Thavendiranathan , Martin Penicka , Julie Lemieux
Cardiovascular Imaging 16 ( 3) 269 -278
37
2023
Rationale and design of the strain surveillance of chemotherapy for improving cardiovascular outcomes
Tomoko Negishi , Paaladinesh Thavendiranathan , Kazuaki Negishi , Thomas H Marwick
JACC: Cardiovascular Imaging 8 ( 11) 1098 -1105
11
2018
Abstract P4-10-01: quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)
Michelle Joy Naughton , David Zahrieh , Michael Gnant , Nicholas Zdenkowski
Cancer Research 82 ( 4_Supplement) P4 -P4
1
2022
Quality of life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05)
Michelle Joy Naughton , David Zahrieh , Michael Gnant , Nicholas Zdenkowski
CANCER RESEARCH 82 ( 4)
2022
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis.
Karen A Gelmon , Peter A Fasching , Fergus J Couch , Judith Balmaña
European Journal of Cancer 152 68 -77
13
2021
Results From CONTESSA: A Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2-, Hormone Receptor+ Metastatic Breast Cancer Who Have Previously Received a Taxane
Joyce O'Shaughnessy , Lee Schwartzberg , Martine Piccart , Hope S Rugo
Clinical Advances in Hematology & Oncology ( 2) 12 -13
6
2021